Misbah Tahir - 02 Sep 2025 Form 4 Insider Report for Maze Therapeutics, Inc. (MAZE)

Role: Chief Financial Officer
Signature: /s/ Courtney Phillips, as attorney-in-fact
Issuer symbol: MAZE
Transactions as of: 02 Sep 2025
Net transactions value: $0
Form type: 4
Filing time: 02 Sep 2025, 18:30:50 UTC
Previous filing: 25 Jul 2025
Next filing: 03 Mar 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Tahir Misbah	Chief Financial Officer	C/O MAZE THERAPEUTICS, INC., 171 OYSTER POINT BOULEVARD, SUITE 300, SOUTH SAN FRANCISCO	/s/ Courtney Phillips, as attorney-in-fact	02 Sep 2025	0001787359

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MAZE	Stock Option (Right to Buy)	Award	$0	+325,000		$0.000000	325,000	02 Sep 2025	Common Stock	325,000	$15.32	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option shall vest as to 1/4th of the total award on September 2, 2026, and thereafter shall vest as to 1/48th of the total award on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date.